“Sulindac, a known anti-inflammatory drug, can protect against oxidative damage due to age-related macular degeneration (AMD), scientists have found,” according to Science Digest. “Their studies suggest that sulindac could be an inexpensive and relatively non-toxic therapeutic approach for treating AMD, one of the primary causes of vision loss in the elderly. AMD gradually destroys sharp, central vision, which is needed for seeing objects clearly and for common daily tasks such as reading and driving. Currently, no cures exist for the majority of AMD cases.” Read more.
No comments:
Post a Comment